We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$426M
Cap. Flow
+$459M
Cap. Flow %
39.34%
Top 10 Hldgs %
6.63%
Holding
2,667
New
887
Increased
542
Reduced
345
Closed
877

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.6M
2
META icon
Meta Platforms (Facebook)
META
+$9.1M
3
MSFT icon
Microsoft
MSFT
+$8.07M
4
CVX icon
Chevron
CVX
+$5.32M
5
DECK icon
Deckers Outdoor
DECK
+$4.36M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.1M
2
GE icon
GE Aerospace
GE
+$3.43M
3
AZO icon
AutoZone
AZO
+$3.1M
4
MS icon
Morgan Stanley
MS
+$2.66M
5
BKR icon
Baker Hughes
BKR
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Industrials 14.87%
3 Healthcare 14.62%
4 Consumer Discretionary 13.4%
5 Financials 12.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VINC
1651
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$14.7K ﹤0.01%
+909
New +$22.8K
ABVC icon
1652
ABVC BioPharma
ABVC
$27.6M
$14.7K ﹤0.01%
+18,944
New +$19.5K
MRDB
1653
DELISTED
MariaDB plc
MRDB
$14.6K ﹤0.01%
27,307
+9,510
+53% +$4.84K
SJ icon
1654
Scienjoy Holding
SJ
$39.1M
$14.5K ﹤0.01%
15,231
-35,612
-70% -$34.6K
BCTX
1655
Briacell Therapeutics
BCTX
$30.2M
$14.1K ﹤0.01%
+82
New +$23.2K
SPRB
1656
Spruce Biosciences
SPRB
$114M
$14.1K ﹤0.01%
362
-395
-52% -$21.2K
NVVE
1657
DELISTED
Nuvve Holding Corp
NVVE
$13.9K ﹤0.01%
2
SGMO
1658
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$13.9K ﹤0.01%
38,735
+12,711
+49% +$6.87K
CMMB
1659
Chemomab Therapeutics
CMMB
$10.5M
$13.9K ﹤0.01%
+3,767
New +$13K
EMKR
1660
DELISTED
Emcore Corp
EMKR
$13.8K ﹤0.01%
11,669
+8,605
+281% +$15.9K
PASG icon
1661
Passage Bio
PASG
$14.7M
$13.5K ﹤0.01%
852
-1,296
-60% -$31.7K
CCM
1662
Concord Medical Services
CCM
$20M
$13.4K ﹤0.01%
+1,410
New +$9.45K
OMH icon
1663
Ohmyhome Ltd
OMH
$3.47M
$13.4K ﹤0.01%
+2,372
New +$14.4K
CREG
1664
DELISTED
Smart Powerr
CREG
$13.3K ﹤0.01%
129
+25
+24% +$2.7K
WLDS icon
1665
Wearable Devices
WLDS
$8.39M
$13.3K ﹤0.01%
32
+13
+68% +$3.99K
RR icon
1666
Richtech Robotics
RR
$322M
$13.1K ﹤0.01%
+10,021
New +$13.5K
HYFT
1667
MindWalk Holdings
HYFT
$63.5M
$12.8K ﹤0.01%
+12,695
New +$15.1K
PMEC icon
1668
Primech Holdings
PMEC
$16.1M
$12.7K ﹤0.01%
+22,365
New +$14.8K
RVSN icon
1669
Rail Vision
RVSN
$9.03M
$12.7K ﹤0.01%
+572
New +$18.9K
ALGS icon
1670
Aligos Therapeutics
ALGS
$26.3M
$12.5K ﹤0.01%
1,426
-369
-21% -$6.49K
DFLI icon
1671
Dragonfly Energy
DFLI
$16.8M
$12.4K ﹤0.01%
+163
New +$12.6K
SONM icon
1672
DNA X Inc
SONM
$4.51M
$12.4K ﹤0.01%
+69
New +$7.52K
ADAP
1673
DELISTED
Adaptimmune Therapeutics
ADAP
$12.1K ﹤0.01%
12,399
-3,553
-22% -$3.9K
COOT
1674
Australian Oilseeds Holdings
COOT
$11.2M
$12K ﹤0.01%
+12,385
New +$14.5K
VATE icon
1675
INNOVATE Corp
VATE
$106M
$11.8K ﹤0.01%
+1,955
New +$12.9K

Similar funds

XTX Topco's Q2 2024 Portfolio in Review

As of Q2 2024, XTX Topco held 2,667 positions worth $1.17B, up 57% from $742M the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

XTX Topco deployed $459M of net new capital in Q2 2024, opening 887 new positions and adding to 542 existing holdings. Its largest new stake was RTX Corp: 40,074 shares worth $4.02M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was GE Aerospace, an estimated $3.43M trimmed.

  • XTX Topco's largest Q2 2024 buy was RTX Corp: 40,074 shares worth $4.02M.
  • XTX Topco added most to Apple in Q2 2024, an estimated $12.6M increase.
  • XTX Topco's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $3.43M.
  • XTX Topco fully exited Tesla in Q2 2024, selling an estimated $4.1M.
  • XTX Topco's ten largest holdings make up 6.6% of its $1.17B portfolio in Q2 2024.
  • XTX Topco opened 887 new positions and closed 877 in Q2 2024.
  • XTX Topco's portfolio value rose 57% quarter-over-quarter to $1.17B.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.